表紙:薬剤溶出ステントの世界市場:業界動向、シェア、規模、成長、機会、予測(2022年~2027年)
市場調査レポート
商品コード
1053510

薬剤溶出ステントの世界市場:業界動向、シェア、規模、成長、機会、予測(2022年~2027年)

Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 148 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
薬剤溶出ステントの世界市場:業界動向、シェア、規模、成長、機会、予測(2022年~2027年)
出版日: 2022年01月10日
発行: IMARC Services Private Limited
ページ情報: 英文 148 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の薬剤溶出ステントの市場規模は、2021年の73億米ドルから、2027年には108億米ドルになると予測されており、2022年から2027年までの予測期間中のCAGRは6.50%となっています。

慢性的な病気にかかりやすい高齢者人口の増加は、市場の成長を促す重要な要因の一つとなっています。また、不健康な食生活、運動不足、座りっぱなしの生活などが原因で、心血管疾患が増加していることも、市場の成長を後押ししています。さらに、生体吸収型ステントの発売など、さまざまな技術的進歩が市場の成長を後押ししています。

当レポートでは、世界の薬剤溶出ステント市場について調査しており、市場概要、市場分析、競合情勢、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の薬剤溶出ステント市場

  • 市場概要
  • 市場実績
  • COVID-19の影響

第6章 市場の内訳:コーティング別

  • ポリマーベースのコーティング
  • ポリマーフリーのコーティング

第7章 市場の内訳:薬剤別

  • シロリムス
  • パクリタキセル
  • ゾタロリムス
  • エベロリムス
  • ビオリムス
  • その他

第8章 市場の内訳:ステントプラットフォーム別

  • ステンレス鋼
  • コバルト-クロム
  • プラチナ-クロム
  • ニチノール
  • その他

第9章 市場の内訳:世代別

  • 第一世代
  • 第二世代
  • 第三世代
  • 第四世代

第10章 市場の内訳:アプリケーション別

  • 冠動脈疾患
  • 末梢動脈疾患

第11章 市場の内訳:エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第12章 市場の内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東とアフリカ
    • 市場の内訳:国別

第13章 SWOT分析

第14章 バリューチェーン分析

第15章 ポーターのファイブフォース分析

第16章 価格分析

第17章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biosensors International Group Ltd.
    • Biotronik
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Cook Medical LLC(Cook Group Incorporated)
    • Lepu Medical Technology(Beijing)Co. Ltd.
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Sino Medical Sciences Technology Inc.
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2021
  • Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2021
  • Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2021
  • Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2021
  • Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2021
  • Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2021
  • Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2021
  • Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2021
  • Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
  • Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
  • Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million US$), 2022-2027
  • Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million US$), 2022-2027
  • Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million US$), 2022-2027
  • Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million US$), 2022-2027
  • Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million US$), 2022-2027
  • Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million US$), 2022-2027
  • Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
  • Table 10: Global: Drug-Eluting Stents Market: Key Players
目次
Product Code: SR0122A257_Report

The global drug-eluting stents market reached a value of US$ 7.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.8 Billion by 2027, exhibiting a CAGR of 6.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

A drug-eluting stent (DES) is a coronary device that is used for the slow release of drugs in peripheral or coronary arteries to block cell proliferation and promote a healthy flow of blood. It consists of a metallic stent, polymer coating and anti-restenosis drug. The stent is coated with medications that assist the arteries to remain smooth and ensure adequate blood flow. DES is widely used to treat blockages in heart arteries, prevent plaque buildup, blood clots and reduce repeated revascularization. The stent is minimally invasive (MI) and offers lower restenosis rates, enhanced vessel healing and reduced need for prolonged dual antiplatelet therapy.

Drug-Eluting Stents Market Trends:

  • The rising geriatric population prone to chronic medical ailments is one of the key factors driving the growth of the market. DES is widely utilized in patients with a high risk of developing arterial disorders as the stents aid in reducing the need for invasive procedures, such as coronary artery bypass surgeries. Additionally, the increasing prevalence of cardiovascular diseases due to the unhealthy dietary patterns, lack of physical activity and sedentary lifestyles of the masses is favoring the market growth. Moreover, various technological advancements, such as the launch of bioresorbable stents, are providing a thrust to the market growth. These stents are easily dissolvable in the body and reduce the risk of developing stent thrombosis. In line with this, the widespread adoption of stents with polymer-free coatings is positively impacting the market growth. These stents exhibit a higher drug loading capacity and quicker drug-eluting rate. Other factors, including the rising incidence of abnormal heart rhythms, heart failure and heart attack disease, along with the increasing demand for MI techniques among the masses, are anticipated to drive the market toward growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global drug-eluting stents market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on coating, drug, stent platform, generation, application and end user.

Breakup by Coating:

  • Polymer Based Coating
  • Polymer Free Coating

Breakup by Drug:

  • Sirolimus
  • Paclitaxel
  • Zotarolimus
  • Everolimus
  • Biolimus
  • Others

Breakup by Stent Platform:

  • Stainless-steel
  • Cobalt-Chromium
  • Platinum-Chromium
  • Nitinol
  • Others

Breakup by Generation:

  • 1st Generation
  • 2nd Generation
  • 3rd Generation
  • 4th Generation

Breakup by Application:

  • Coronary Artery Disease
  • Peripheral Artery Disease

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation. Key Questions Answered in This Report:

  • How has the global drug-eluting stents market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug-eluting stents market?
  • What are the key regional markets?
  • What is the breakup of the market based on the coating?
  • What is the breakup of the market based on the drug?
  • What is the breakup of the market based on the stent platform?
  • What is the breakup of the market based on the generation?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug-eluting stents market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug-Eluting Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Coating

  • 6.1 Polymer Based Coating
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Polymer Free Coating
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug

  • 7.1 Sirolimus
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Paclitaxel
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Zotarolimus
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Everolimus
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Biolimus
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Stent Platform

  • 8.1 Stainless-steel
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cobalt-Chromium
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Platinum-Chromium
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nitinol
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Generation

  • 9.1 1st Generation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 2nd Generation
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 3rd Generation
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 4th Generation
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Coronary Artery Disease
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Peripheral Artery Disease
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Ambulatory Surgical Centers
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Abbott Laboratories
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
      • 17.3.1.3 Financials
      • 17.3.1.4 SWOT Analysis
    • 17.3.2 B. Braun Melsungen AG
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 SWOT Analysis
    • 17.3.3 Biosensors International Group Ltd.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
    • 17.3.4 Biotronik
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 SWOT Analysis
    • 17.3.5 Boston Scientific Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
      • 17.3.5.3 Financials
      • 17.3.5.4 SWOT Analysis
    • 17.3.6 Cardinal Health Inc.
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
      • 17.3.6.3 Financials
      • 17.3.6.4 SWOT Analysis
    • 17.3.7 Cook Medical LLC (Cook Group Incorporated)
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 SWOT Analysis
    • 17.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
    • 17.3.9 Medtronic plc
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
      • 17.3.9.3 Financials
      • 17.3.9.4 SWOT Analysis
    • 17.3.10 MicroPort Scientific Corporation
      • 17.3.10.1 Company Overview
      • 17.3.10.2 Product Portfolio
    • 17.3.11 Sino Medical Sciences Technology Inc.
      • 17.3.11.1 Company Overview
      • 17.3.11.2 Product Portfolio
    • 17.3.12 Terumo Corporation
      • 17.3.12.1 Company Overview
      • 17.3.12.2 Product Portfolio
      • 17.3.12.3 Financials
      • 17.3.12.4 SWOT Analysis